A 48-year-old woman with alcohol dependence is admitted for medically supervised detoxification. She has a history of two prior withdrawal seizures and mild hepatic cirrhosis (Child-Pugh score 6). Which benzodiazepine is the preferred choice for her acute alcohol withdrawal?

Explanation

## Benzodiazepine Selection in Alcohol Withdrawal with Liver Disease **Key Point:** In patients with hepatic impairment, lorazepam is preferred because it undergoes glucuronidation (not hepatic oxidation) and has no active metabolites, minimizing accumulation and hepatotoxicity risk. ### Pharmacokinetic Comparison of Benzodiazepines | Benzodiazepine | Metabolism | Active Metabolites | Half-life | Liver Disease | Seizure Prevention | |---|---|---|---|---|---| | **Lorazepam** | Glucuronidation | None | 12–18 hrs | ✓ Safe | ✓ Excellent | | **Diazepam** | Oxidation (CYP3A4) | Yes (desmethyl, oxazepam) | 20–70 hrs | ✗ Risky | ✓ Excellent | | **Chlordiazepoxide** | Oxidation (CYP3A4) | Yes (desmethyl, demoxepam) | 5–30 hrs | ✗ Risky | ✓ Good | | **Oxazepam** | Glucuronidation | None | 5–20 hrs | ✓ Safe | ~ Fair | **High-Yield:** Lorazepam is the **gold standard in cirrhosis** because: 1. **No hepatic oxidation** — glucuronidation pathway is preserved even in advanced liver disease. 2. **No active metabolites** — no risk of accumulation or prolonged CNS depression. 3. **Shorter half-life than diazepam** — allows more flexible dosing and faster clearance if overdose occurs. 4. **Proven efficacy** — prevents seizures as reliably as diazepam in withdrawal. ### Clinical Context: This Patient's Risk Factors - **Prior withdrawal seizures** → requires potent, reliable anticonvulsant (lorazepam ✓). - **Mild cirrhosis (Child-Pugh 6)** → hepatic metabolism is impaired; lorazepam avoids oxidation (lorazepam ✓). - **Female, age 48** → no additional metabolic contraindications. **Clinical Pearl:** Although oxazepam also uses glucuronidation, it has a shorter half-life and weaker seizure-preventive efficacy compared to lorazepam. Lorazepam combines safety in liver disease with superior seizure prevention. ### Why Not the Others in This Case? - **Diazepam:** Long-acting metabolites accumulate in cirrhosis, risking hepatic encephalopathy and prolonged sedation. - **Chlordiazepoxide:** Oxidative metabolism impaired in cirrhosis; active metabolites accumulate. - **Oxazepam:** Safe in liver disease but lower potency; less reliable for seizure prevention in a patient with prior withdrawal seizures. [cite:Harrison 21e Ch 474; Goodman & Gilman 13e Ch 28]